TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Acasti Pharma ( (ACST) ) has shared an announcement.
At a recent shareholder meeting with strong attendance, several key decisions were made affecting the company’s future. Shareholders elected director nominees and appointed KPMG as the independent auditor. Additionally, executive compensation was approved on an advisory basis. The company will undergo a significant transition, moving from Québec to British Columbia, and then further domesticating to Delaware. Finally, the shareholders sanctioned the 2024 Equity Incentive Plan, setting the stage for strategic corporate and financial advancements.
For detailed information about ACST stock, go to TipRanks’ Stock Analysis page.